Materialise NV (MTLS) AI Stock Analysis

Materialise NV specializes in additive manufacturing and medical software, as well as providing 3D printing services across the Americas, Europe, Africa, and the Asia-Pacific region. The company operates through three primary segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software unit develops applications that connect 3D printers with design tools such as CAD/CAM packages and 3D scanners, serving machine makers, industrial producers, and service bureaus. The Materialise Medical segment delivers medical-image-based analysis and engineering software used for patient-specific design of surgical devices and implants, serving medical device firms, hospitals, and research institutes.

Materialise grew its revenue at an 8.6% CAGR from FY2020 through FY2025. Annual revenue expanded from $205.4M in FY2021 to a peak of $266.8M in FY2024 before falling 3.6% to $257.1M in FY2025. Net income was $13.2M in FY2021, fell to -$2.1M in FY2022, and stood at $7.4M in FY2025 with a net margin of 2.9%. Gross margin has remained relatively steady, ending FY2025 at 57.1%. For the latest quarter ended June 30, 2026, quarterly revenue increased 8.1% year-over-year, while quarterly earnings grew 1595.6%. Trailing twelve-month revenue reached $272.8M, supported by a profit margin of 4.8%.

As of June 30, 2026, Materialise held $133.7M in cash and short-term investments against $59.5M in total debt, leaving net cash of $74.2M. Total assets stood at $417.5M and shareholders' equity was $256.2M. Liquidity is supported by a current ratio of 2.41 and a debt-to-equity ratio of 0.23. Operating cash flow in FY2025 was $22.7M, which supported $13.5M in capital expenditures, leaving free cash flow of $9.1M. Over the last five years, the company reduced its share count by 1.2%.

Materialise trades at an enterprise value of $370.9M and a market capitalization of $460.6M. Its trailing P/E of 28.6x is slightly above the 28.1x median of its US-listed Technology peers. However, its forward P/E of 625.0x stands well above the peer median of 18.8x. On an asset and sales basis, its price-to-sales multiple of 1.7x and EV-to-EBITDA of 8.4x compare to peer medians of 2.8x and 16.6x, respectively. Over the trailing 12 months, MTLS returned 30.9% versus 16.8% for the S&P 500 (SPY), though its 5-year return of -61.4% lags the S&P 500's 83.0%.

Wall Street coverage tracked on Materialise includes 2 Strong Buy ratings and 1 Hold rating, with no Sell recommendations. The mean price target is $8.82, representing a 10.3% premium over the last close of $8.00 on October 16, 2026. For the current fiscal year ending December 31, 2026, consensus estimates project revenue of $278.3M and EPS of $0.19, reflecting 23.1% EPS growth. MTLS has beaten EPS estimates in each of the last 4 quarters, and its next earnings report is scheduled for October 28, 2026.

This page is an AI-written research summary of Materialise NV (MTLS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: MTLS income statement, MTLS balance sheet, MTLS key metrics, MTLS analyst forecast, MTLS chart. See the MTLS stock overview for the latest quote and news.